Presenter: K. Torfs
Koen Torfs is Vice President Health Economics, Market Access and Reimbursement for Europe, Middle East and Africa at Janssen, pharmaceutical companies of Johnson & Johnson.
Koen Torfs has a degree in political and social sciences from the Catholic University of Leuven and has extensive experience in health care economics in general and pharmaceutical economics in particular. Since 1986 he has studied health care from many different perspectives. He worked in academia as a research fellow in applied health economics at the university of Antwerp, Belgium ; in consulting at Biopharma/Laboratoires Simon (today SGS Life Sciences), Wavre, Belgium ; in non-profit at the EORTC in Brussels, Belgium, between 1993 and 1997 ; and for Janssen in various positions since 1997.
In his current responsibility Koen Torfs supports and supervises access and reimbursement policies of innovative Janssen pharmaceutical products across countries, across the products’ lifecycles and across disease areas like cancer, hepatitis C, HIV, schizophrenia, alzheimer’s disease and diabetes. He has been involved in reimbursement discussions and Health Technology Assessment processes with NICE, IQWIG and other governmental organisations from the early days and has developed an in depth understanding of the roles and needs of the various stakeholders and the complex interdependencies between industrial policy, healthcare and access policies and the pharmaceutical innovation process, as well as the role of non-profit organisations and patient advocacy organisations in this respect.
Koen Torfs is a member of ASCO, ESMO and ISPOR. He has been/is active in industry committees and has contributed to many publications in the field of economic evaluation and on topics such as publication bias.